WP
GMAB icon

Woodline Partners’s Genmab GMAB Stock Holding History

Woodline Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66M Buy
+133,387
New +$3.54M 0.01% 754
2026
Q1 		– Sell
-369,188
Closed -$11.4M – 1085
2025
Q4 		$11.4M Sell
369,188
-89,988
-20% -$2.8M 0.04% 428
2025
Q3 		$14.1M Sell
459,176
-34,330
-7% -$837K 0.07% 353
2025
Q2 		$10.2M Buy
+493,506
New +$10.1M 0.05% 430

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Woodline Partners's GMAB Position: Q2 2026 in Review

Woodline Partners opened a new position in Genmab (GMAB) in Q2 2026: 133,387 shares worth $3.66M. The stake represents 0.01% of the portfolio and ranks #754 among its holdings. This is a return to the name: Woodline Partners previously reported a position in GMAB as recently as Q4 2025.

Woodline Partners first reported a position in GMAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $14.1M in Q3 2025. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Woodline Partners held 133,387 shares of Genmab worth $3.66M as of Q2 2026.
  • Genmab was a new Woodline Partners position in Q2 2026.
  • Genmab made up 0.01% of Woodline Partners's portfolio in Q2 2026, its #754 holding.
  • Woodline Partners first reported a position in Genmab in Q2 2025 and has held it in 4 quarters since.
  • Woodline Partners's Genmab position peaked at $14.1M in Q3 2025.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.